connection error:
SQLSTATE[HY000] [2002] php_network_getaddresses: getaddrinfo failed: Name or service not knownconnection not set
Mayberry Research 2021-10-05T03:32:45-05:00

Paramount Trading (Jamaica) Limited (PTL) – Announcement of Material Contracts

Date: February 13, 2020 Please see the attached press release from Paramount Trading (Jamaica) Limited (PTL). Press-Release-Paramount-Trading-Jamaica-Limiteds-Announcement-of-Material-Contracts   Disclaimer: Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report. Company Disclosure -The information contained herein has been obtained from

INDIES reports 9% increase in year end net profits

February 12, 2020 Indies Pharma Jamaica Limited (INDIES) based on audited results, reported revenues for the twelve months ended October 31, 2019 of $729.45 million, an increase of 15% when compared with the $636.17 million booked last year. Cost of sales amounted to a total of $268.78 million relative to the $243.38 million reported for the same period last year, a 10% increase year over year. As such, gross profit increased 17% to a total of $460.67 million relative to the $392.79 million for the FY2018. Other operating income for the year ended amounted to $782,450 a decline of 4%

Dividend Consideration: Dolphin Cove Limited (DCOVE)

Date: February 12, 2020 Dolphin Cove Limited (DCOVE) has advised that at a Board of Directors’ meeting scheduled for February 24, 2020, consideration will be given to the payment of an interim dividend.   Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer(s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view(s) expressed by that research analyst in this research